Molecular determinants for enzalutamide-induced transcription in prostate cancer
Fuwen Yuan(Duke University), Qianben Wang(The University of Texas at San Antonio Health Science Center), Jiaoti Huang(Space Science Institute), Andrew J. Armstrong(Duke University), Zhong Chen(Sun Yat-sen University), Dayong Wu(Shihezi University), Jason A. Somarelli(Duke Medical Center), Hongyan Wang(Anhui Agricultural University), William Hankey(Duke University)
Cited by 66
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
|Molecular Cancer Research|2011|650
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
Nutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance
|Frontiers in Immunology|2019|466